Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy

Stopped Inadequate funding to begin enrolling subjects

Conditions

• Lymphoma, B-Cell

Interventions

• DRUG: R-Chop and Roflumilast

Sponsor

The University of Texas Health Science Center at San Antonio